Venus Medtech International

As we close another year filled with innovation, collaboration, and life-changing solutions, we extend our deepest gratitude to our incredible network of partners, healthcare providers, patients, and innovators. Your support empowers our mission to give every heart a renewed beat and a second chance. This holiday season may your hearts be filled with joy, good health, and cherished moments. Let’s remember, it’s not just about unwrapping gifts but also opening our hearts to endless possibilities. Here’s to a brighter, healthier future together! Happy Holidays and a Happy New Year! ✨🫀✨ #TTVR #TMVR #TAVR #TPVR #happynewyear #VenusMedtech #Cardiovalve

🌟 Inspiring Moments from ICI Meeting 2024 🌟 Innovation and collaboration took center stage at ICI 2024, and we're excited to share the highlights! A special thank you to the esteemed Prof. Antonio Colombo, Prof. Karl-Heinz Kuck for joining us in Israel despite the challenging times. your unwavering dedication, determination, and professional contributions inspire us all. During the conference, Prof. Kuck presented: The TARGET study's excellent progress, with patient recruitment well on track and a recent successful case using our mitral valve technology in Portugal, marking a significant milestone as we gear up to renew our transcatheter mitral valve program in 2025. 🎖️ Adding to the excitement, Prof. Kuck was honored with the ICI Innovation Award for Lifetime Achievement! This prestigious recognition celebrates his pioneering work in: catheter ablation techniques, global leadership in atrial fibrillation treatment, groundbreaking research, and remarkable education in cardiac electrophysiology. We continue to shape the future of cardiovascular care and privileged to partner with such a visionary leader as we push the boundaries of innovation in structural heart disease. Thank you to everyone who joined us at ICI 2024. ✨ #ICIMeeting2024 #VenusMedtech #Cardiovalve #TTVR #TMVR

🤍 Join Us at ICI Meeting 2024 💙 We're excited to participate in the International Conference for Innovations in Cardiovascular Interventions (ICI) this week at the David InterContinental Hotel in Tel Aviv. The world-renowned cardiologist Prof. Karl-Heinz Kuck will present the latest clinical updates on the Cardiovalve Tricuspid Replacement System during the session: "Tricuspid Valve - New Challenges." Mark your calendars for Monday I December 9th I 14:36 I Hall B. At the ICI Meeting, physicians, entrepreneurs, and industry leaders gather to spark innovations shaping the future of cardiovascular care. Connect with us to explore the cutting-edge advancements transforming patient outcomes in structural heart disease. #ICIMeeting2024 #VenusMedtech #Cardiovalve #TTVR #TMVR

Thank You for an Extraordinary PCR London Valves 2024! ✨ What an incredible journey these past three days have been! The conference halls were alive with innovation and the energy of bright minds from the global cardiovascular community. We are deeply grateful for your overwhelming response to: Our innovative valve solutions showcase I The scientific symposium: Innovation Never Stops: Cardiovalve in ACTION! Expert-led presentations and hands-on demonstrations. Your enthusiasm has made this event truly unforgettable. As we continue advancing TTVR, TMVR, TAVR, and TPVR, your insights inspire us to push the boundaries of what's possible in heart care. Innovation never stops—and neither do we. We look forward to sharing more groundbreaking developments at PCR London Valves 2025! ✨ #TTVR #TMVR #TAVR #TPVR #PCRLondonvalves #VenusMedtech #Cardiovalve

✨ An Inspiring Day 1 at PCR London Valves 2024! ✨ The opening day of PCR London Valves was nothing short of remarkable! Cardiovalve TTVR Scientific Session offered invaluable insights into advancing care for patients with complex heart valve conditions.   Our esteemed faculty shared their expertise to illuminate the anatomical and imaging challenges of Transcatheter Tricuspid Valve Replacement (TTVR) while unveiling the latest clinical advancements in this transformative therapy. A heartfelt thank you to our incredible speakers: Dr. Didier Tchetche , Dr. Xavier Freixa , Prof. Sergio Berti, Dr. Federico De Marco, and Dr. Rodrigo Estévez Loureiro, MD, PhD, FESC. Your contributions have truly framed Cardiovalve in Action and inspired a deeper understanding of the future of TTVR! Visit us at Booth #25 to continue the conversation and explore our innovative valve solutions! ✨ #TTVR #TMVR #TAVR #TPVR #PCRLondonvalves #VenusMedtech #Cardiovalve

The Countdown is on! PCR London Valves 2024 is just around the corner, and our team is putting final touches to showcase our precision craftsmanship and unique transcatheter innovations. From a unique booth display to insightful sessions, we're bringing an exciting experience to London! 📅 Don't Miss the Venus Medtech Symposium I Nov 24 at 17:20 I Cardiovalve in ACTION! Dive into the latest advancements in TTVR with expert insights and live demonstrations. Additionally awaits you at PCR London Valves: * Magnified views of our innovative valve solutions * Our team of experts ready to connect and collaborate * Hands-on experiences and in-depth discussions * Latest developments in TTVR, TMVR, TAVR, and TPVR. Visit us at Booth #25 to magnify the future of heart care together ✨ 🔗 For more details visit: venusmedtechconference.com #PCRLondonValves #VenusMedtech #Cardiovalve #TMVR #TTVR #TAVR #TPVR

🎯 Join Our Scientific Symposium at PCR London Valves 2024! 🎯 Innovation Never Stops:Cardiovalve in ACTION! Sunday I November 24 I 17:20-18:20 I Room 4 We're excited to present our expert-led symposium, chaired by Dr. Didier Tchetche and co-chaired by Prof. Georg Nickenig. Join us for an in-depth look at the future of TTVR and Cardiovalve innovations! Symposium Highlights:   - Latest Clinical Updates on the Cardiovalve Tricuspid Replacement System - Live-in-a-Box Case Demonstration - TTVR Efficacy in Rheumatic Tricuspid Valve Regurgitation - Hot News in Imaging: TTVR Using Intracardiac Echocardiography (ICE) - Rapid Learning Curve Insights from a Single-Site Experience   Join us to discover the innovations driving the future of transcatheter therapies and transforming patient care. 🔗 For more details visit: venusmedtechconference.com #PCRLondonValves #VenusMedtech #Cardiovalve #TMVR #TTVR #TAVR #TPVR

🌟Our Team of Experts Awaits You at PCR London Valves, Nov 24-26🌟 We're bringing an exceptional team to PCR London Valves, ready to share insights and explore the future of heart valve solutions with you! Our experts—including Amir Gross (CEO, Cardiovalve), Nitza Shoham, PhD (VP Clinical), along with Tom Pasler (VP Therapy Development). Our core team will be offering insights and hands-on experiences at the exhibition area. Connect with us to: • Discover how patients benefit from our unique transcatheter approach • Learn the locations of our active study centers • Explore collaboration opportunities • Share ideas for future clinical development. Experience firsthand our pioneering TMVR, TTVR, TAVR, and TPVR solutions, presented by our experts. Save the date and visit us at booth #25—let's magnify the future of heart care together 🌟 #PCRLondonValves #VenusMedtech #Cardiovalve #TMVR #TTVR #TAVR #TPVR

✨ Magnify Innovation, Experience Quality at PCR London Valves 2024 ✨ We're excited to head back to London for PCR London Valves 2024—the leading event for valvular heart disease—on November 24-26. Visit us at booth #25 for an up-close look at our innovative transcatheter solutions. Through unique magnifying displays, explore the intricate designs of our TMVR, TTVR, TAVR, and TPVR technologies that are transforming heart care. 🔍 What to Expect:  * Discover innovations for all four heart valves  * Engage with our expert team  * Get updates on our latest clinical trial advancements  * Attend expert-led presentations and scientific sessions on the future of transcatheter therapies. We're counting down to PCR London Valves and look forward to connecting with you! Let's magnify the future of heart care together✨ #PCRLondonValves #VenusMedtech #Cardiovalve #TMVR #TTVR #TAVR #TPVR

Thank you Priv.-Doz. Dr. Christian Frerker for your insightful presentation on the Cardiovalve clinical program at TCT2024. We also extend our gratitude to the investigators in the TARGET study, whose invaluable contributions drive its success. As leaders in transcatheter tricuspid valve replacement therapy, we are grateful for your support in enhancing patient care. With the TARGET study on track, we look forward to sharing promising initial results next year. We're also excited about the AHEAD II study, with recruitment starting in Q1 2025, featuring an enhanced delivery system for the Mitral position. Thank you to everyone who joined us this year. We look forward to seeing you at TCT2025! Stay tuned for more updates 💙🤍 💙 #TCT2024 #VENUSMEDTECH #CARDIOVALVE #TTVR #TMVR